Gonzalgo Mark L, Patil Nilesh, Su Li-Ming, Patel Vipul R
Department of Urology, James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Marburg 145, Baltimore, MD 21287, USA.
Urol Clin North Am. 2008 Aug;35(3):489-504, ix. doi: 10.1016/j.ucl.2008.05.007.
For clinically localized prostate cancer, radical prostatectomy remains the "gold standard" treatment. New forms of minimally invasive therapies are sought out by patients, however, because of the potential morbidity associated with open surgery. With quality-of-life aspects influencing patient decision making, minimally invasive therapeutic modalities have generated great interest among patients. Laparoscopic radical prostatectomy, robotic-assisted laparoscopic prostatectomy, brachytherapy, cryotherapy, and high-intensity focused ultrasound are all considered to be minimally invasive treatment options for the management of clinically localized prostate cancer.
对于临床局限性前列腺癌,根治性前列腺切除术仍然是“金标准”治疗方法。然而,由于开放手术存在潜在的发病率,患者寻求新的微创治疗形式。随着生活质量因素影响患者的决策,微创治疗方式引起了患者的极大兴趣。腹腔镜根治性前列腺切除术、机器人辅助腹腔镜前列腺切除术、近距离放射疗法、冷冻疗法和高强度聚焦超声都被认为是治疗临床局限性前列腺癌的微创治疗选择。